Genius Group increases Bitcoin Treasury 40% to total purchase of 153 Bitcoin for $14 million
SINGAPORE, Nov. 21, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading […]
Constellium Receives France 2030 Award for the “Wing of the Future” Project on the Design of the Sustainable Aircraft of Tomorrow
PARIS, Nov. 21, 2024 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) announced that it received a France 2030 award for […]
Provident Bank Strengthens Human Resources Team with Senior Vice President to Drive the Bank’s People Development Strategy
ISELIN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) — Provident Bank, a leading New Jersey-based financial institution, is pleased to announce that […]
TSX News -
BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study
Phase 1/2 dose escalation study to evaluate BriaCell’s personalized next generation immunotherapy treatment in metastatic breast cancer Bria-OTS™ to be […]
Alaska Energy Metals Discovers Broad Zones Of Nickel With Other Critical Metals At The Canwell Property, Nikolai Project, Alaska
DISTRICT – WIDE POTENTIAL OF THE NIKOLAI ULTRAMAFIC INTRUSIONS HAS BEEN DEMONSTRATED HIGHLIGHTS Alaska Energy Metals received assay results from […]
TSX News -
Bombardier’s Global 7500 Business Jet Soars to New Heights, Continues Record-Setting Pace with 75 Speed Records
Industry-defining business aircraft establishes new record-setting missions including essential city pairs from Miami to São Paulo, Tokyo to Los Angeles, […]
Entourage Health to Host Third Quarter 2024 Earnings Conference Call
TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a […]
HydroGraph Announces Two Strategic Partnerships to Drive Innovation
TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (FRA: M98) (the “Company” or […]
Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium
[212Pb]VMT-α-NET continued to have a favorable safety profile, with no dose-limiting toxicities observed at the two doses tested (2.5 and […]
Lifeist Appoints Andrea Judge as Chief Executive Officer and Joins the Board of Directors
TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), […]
